Pharmaco - Press Releases

Date	Title	Company
25-Nov-2020	Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) as Second-Line Treatment for Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma	Bristol Myers Squibb
25-Nov-2020	GSK starts phase 3 study of RSV maternal candidate vaccine	GSK
25-Nov-2020	AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19	Astra Zeneca
25-Nov-2020	PA Consulting welcomes Cooper Perkins, enhancing product engineering capabilities as part of its end-to-end innovation offering	PA Consulting
25-Nov-2020	The Himalaya Drug Company Introduces Q-DEE Range of Mouth Dissolving Tablets for Immunity and Cramps	The Himalaya Drug Company
24-Nov-2020	China Biologic Reports Financial Results for the Third Quarter of 2020	China Biologic Products Holdings, Inc.
24-Nov-2020	Pharmacy Groups Say New Rebate Rule Does Not Do Enough to Support Patients	American Pharmacists Association
24-Nov-2020	Second interim analysis of clinical trial data showed a 91.4% efficacy for the Sputnik V vaccine on day 28 after the first dose; vaccine efficacy is over 95% 42 days after the first dose	Russian Direct Investment Fund (RDIF)
24-Nov-2020	The cost of one dose of the Sputnik V vaccine will be less than $10 for international markets	Russian Direct Investment Fund (RDIF)
24-Nov-2020	MetrioPharm AG: COVID-19 Therapeutic Agent: MetrioPharm Prepares to Conduct a Phase II Clinical Trial	MetrioPharm AG
24-Nov-2020	United Therapeutics Releases Its First Corporate Responsibility Report	United Therapeutics Corporation
24-Nov-2020	Bexmarilimab (Clevegen) development update	Faron Pharmaceuticals Oy
24-Nov-2020	European Commission approves MenQuadfi®, the latest innovation in meningococcal (MenACWY) vaccination for individuals 12 months of age and older	Sanofi
24-Nov-2020	Mustang Bio and Minaris Regenerative Medicine Sign Technology Transfer and GMP Manufacturing Agreement for MB-107 Lentiviral Gene Therapy for X-Linked Severe Combined Immunodeficiency	Mustang Bio
24-Nov-2020	Idorsia announces positive results of the two Japanese registration studies with clazosentan	Idorsia Ltd
24-Nov-2020	GPs and nurses anticipate compromised care over winter for elderly people with type 2 diabetes, according to new survey results	Boehringer Ingelheim
24-Nov-2020	EVOTEC AND RAPPTA THERAPEUTICS ENTER DISCOVERY AND DEVELOPMENT PARTNERSHIP FOCUSED ON ONCOLOGY TARGET	Evotec SE
24-Nov-2020	Polyphor receives award of up to USD 3.3 million from Cystic Fibrosis Foundation to support clinical development of inhaled antibiotic murepavadin	Polyphor AG
24-Nov-2020	Chief Operating Officer Dr. Stefan Glombitza appointed to Formycon AG's Management Board for another Four Years	Formycon AG
24-Nov-2020	NeuroRx and Relief announce initial successful results from expanded access use of RLF-100(TM) (aviptadil) in patients with Critical COVID-19 and Severe Comorbidity: 72% survival seen in ICU patients	RELIEF THERAPEUTICS Holdings AG